Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial
Lopez-Miranda, E; Perez-Garcia, JM; Di Cosimo, S; Brain, E; Ravnik, M; Escriva-de-Romani, S; Vidal, M; Gligorov, J; Borstnar, S; Calabuig, L; Sampayo-Cordero, M; Malfettone, A; Llombart-Cussac, A; Suter, TM; Cortes, J
Cortes, J (corresponding author), Med Scientia Innovat Res MedSIR, Dept Med, Ridgewood, NJ 07450 USA.; Cortes, J (corresponding author), Med Scientia Innovat Res MedSIR, Med Dept, Barcelona 08018, Spain.; Cortes, J (corresponding author), Int Breast Canc Ctr IBCC, Med Oncol Dept, Quiron Grp, Barcelona 08022, Spain.; Suter, TM (corresponding author), Univ Bern, Bern Univ Hosp, Dept Cardiol, Inselspital, CH-3010 Bern, Switzerland.; Cortes, J (corresponding author), Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona 08035, Spain.
CANCERS, 2020; 12 (12):
